• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number CXA360005
Device Problem Activation Failure (3270)
Patient Problem Insufficient Information (4580)
Event Date 04/05/2024
Event Type  malfunction  
Event Description
The following information was reported to gore: on (b)(6) 2024, this patient underwent an endovascular treatment for abdominal aortic aneurysm using gore® excluder® conformable aaa endoprosthesis, and gore® excluder® aaa endoprosthesis.The trunk - ipsilateral leg endoprosthesis was deployed approximately 2 cm distal to the lower renal artery.When the aortic extender endoprosthesis was deployed on the proximal side, insufficient deployment was observed.Attempts were made to get full deployment using a balloon catheter or insert a wire into the gap, but these were unsuccessful.No endoleak was observed.The patient tolerated the procedure.
 
Manufacturer Narrative
H3: code "other" was selected as the medical device remains implanted.Return not possible.H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.H6: d12: according to the gore® excluder® conformable aaa endoprosthesis instructions for use, adverse events that may occur and / or require intervention or additional intraoperative procedure time include, but are not limited to: endoprosthesis or delivery system: improper component placement; incomplete component deployment; unintentional/premature component deployment; leading end catheter component retention; component migration; separation of graft material from stent; occlusion; infection; stent fracture; graft material failure, dilatation, erosion, puncture, perigraft flow.H6: the imaging evaluation performed by a clinical imaging specialist showed the following: three radiographic jpegs and one short angiogram movie provided for evaluation.Cannot manipulate the images in any way.(window level, rotate, etc.) jpeg images show a partial aortic extender deployment and attempted/unsuccessful ballooning to fully expand the aortic extender.Movie clip shows the deployment process.Partial deployment of the aortic extender.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Manufacturer Narrative
H6: according to the gore® excluder® conformable aaa endoprosthesis instructions for use, adverse events that may occur and / or require intervention or additional intraoperative procedure time include, but are not limited to: endoprosthesis or delivery system: improper component placement.Narrative: correction of ifu statement.
 
Manufacturer Narrative
Emdr section h6, codes b15 updated to reflect results of investigation.Imaging evaluation summary: the imaging evaluation performed by a clinical imaging specialist showed the following: three radiographic jpegs and one short angiogram movie provided for evaluation.Cannot manipulate the images in any way.(window level, rotate, etc.) the movie clip appears to show a non-continuous (slow) deployment.An attempted ballooning failed to complete the expansion of the aortic extender.Movie clip shows the deployment process.Engineering evaluation summary: the complaint information reports that insufficient deployment of the aortic extender endoprosthesis was observed.The imaging evaluation of the images and movie clip of the deployment process appears to show the device being deployed in a non-continuous manner.The extender deploys from the trailing end to the leading end.The trailing end of the aortic extender opened at a sharp angle before the rest of the graft could open, and the trailing apices became stuck on the inner lumen of the previously implanted trunk-ipsilateral leg endoprosthesis.Upon fully releasing the aortic extender, the trailing end remained stuck on the inner lumen of the trunk.Based on the reported event description, ballooning was not able to address the irregular deployment of the graft; however, no endoleak was observed and the patient tolerated the procedure.Based on the images provided, the findings of the imaging evaluation are consistent with the physician¿s statement that there was ¿insufficient deployment observed¿.The root cause of the insufficient deployment could not be determined, though it is possible the non-continuous deployment contributed to the irregular deployment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
ayako yoshioka
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key19161071
MDR Text Key341476676
Report Number3007284313-2024-03189
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132650972
UDI-Public00733132650972
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P200030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCXA360005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/05/2024
Initial Date FDA Received04/22/2024
Supplement Dates Manufacturer Received04/05/2024
Supplement Dates FDA Received05/01/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/20/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient SexMale
-
-